Emfogen 10 mg (Tablet)
Unit Price: ৳ 25.00 (2 x 10: ৳ 500.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | General pharmaceuticals ltd |
| Also available as |
Title
- Emfogen 10 mg Tablet
Categories
- Medicine
- Diabetes Management
- Cardiovascular Health
Description
- Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor that helps improve glycemic control in adults with type 2 diabetes mellitus and reduces the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Dosage
- 10 mg once daily, taken in the morning, with or without food. Dose may be increased to 25 mg once daily in patients tolerating Empagliflozin.
Indications
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Mode of Action
- Inhibits SGLT2 co-transporters, leading to increased glucose excretion, reduced hyperglycemia, weight loss, and lowered blood pressure
Interaction
- Diuretics - co-administration results in increased urine volume
- Insulin or Insulin Secretagogues - co-administration increases the risk for hypoglycemia
- Positive Urine Glucose Test - not recommended due to increased urinary glucose excretion
- Interference with 1,5-anhydroglucitol (1,5-AG) Assay - not recommended for monitoring glycemic control
Contraindications
- Serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Empagliflozin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Not recommended when breastfeeding.
Precautions & Warnings
- Assessment of renal function recommended prior to initiation
- Not to be initiated in patients with eGFR less than 45 ml/min/1.73 m²
- No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m²
Overdose Effects
- Supportive measures should be employed
- Removal of Emfogen by hemodialysis has not been studied
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Keep in a cool & dry place (below 30° C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure: Image available
Commonly Asked Questions
- What is Emfogen 10 mg Tablet?
- What is Emfogen 10 mg Tablet used for?
- Are there any pregnancy warnings?
- Are there any breast-feeding warnings?
- Does this affect kidney function?
- Does this affect liver function?
- Quick Tips
Quick Tips
- Used alone or together with other diabetes medicines to control blood sugar
- May cause dehydration or increased urination - drink plenty of water
- May cause hypoglycemia - carry sugary food
- Can cause genital fungal and/or urinary tract infections - practice good hygiene
- Monitor blood sugar regularly while taking
- Inform doctor of certain symptoms experienced